Category Archive

Araim Pharmaceuticals’ Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

Vault BioventuresMay 8, 2018Clinical Development, Industry NewsLeave a Comment

Chronic Severe Pain Defines Lives of Sarcoidosis Patients, According to Sarcoidosis/ FSR/ ARAIM Survey Results

Vault BioventuresDecember 21, 2017Clinical Development, Industry NewsLeave a Comment

Share This:

A large proportion of sarcoidosis patients live with severe chronic pain despite the heavy use of painkillers, including opioids, a recent survey found. In addition, pain considerably impacts their walking ability, sleep, and enjoyment of … Read More

J&J reels after FDA finds 'sub-trace' levels of asbestos in its baby powder
Source: Fierce Pharma Published on 2019-10-18 By Eric Sagonowsky
Teva recalls tainted Zantac generics in the U.K.
Source: Fierce Pharma Published on 2019-10-18 By Eric Palmer
Pfizer's Vyndaqel franchise, buoyed by diagnoses, is poised for 'a decisive beat': analyst
Source: Fierce Pharma Published on 2019-10-18 By Angus Liu
Merck to lay off 500 workers around the U.S. in continued shift to innovative meds
Source: Fierce Pharma Published on 2019-10-18 By Eric Sagonowsky
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
Source: Fierce Pharma Published on 2019-10-18 By Kyle Blankenship
Lay the Tech Foundation for IPO Success
Source: Pharma Exec Technology Published on 2019-10-17 By Pharmaceutical Executive
Lay the Tech Foundation for IPO Success
Source: Pharma Exec Technology Published on 2019-10-17 By Pharmaceutical Executive
Tech Tour for the C-Suite: Pharma s Digital Future
Source: Pharma Exec Technology Published on 2019-10-10 By Pharmaceutical Executive
Surfing the Wave: The Patient-Data Puzzle
Source: Pharma Exec Technology Published on 2019-10-09 By Pharmaceutical Executive
Data Shape-Up: Striving to Standardize
Source: Pharma Exec Technology Published on 2019-10-08 By Pharmaceutical Executive
FDA Gains Approval to Revamp New Drug Review Operations
Source: Pharma Exec Regulatory Published on 2019-09-26 By Pharmaceutical Executive
Who Will Head FDA?
Source: Pharma Exec Regulatory Published on 2019-09-12 By Pharmaceutical Executive
The Murky Outlook for Generic Drugs
Source: Pharma Exec Regulatory Published on 2019-09-09 By Pharmaceutical Executive
Sunshine on Marketing, Research Payments Expands
Source: Pharma Exec Regulatory Published on 2019-09-04 By Pharmaceutical Executive
Product Data: Not Just for Regulators
Source: Pharma Exec Regulatory Published on 2019-09-02 By Pharmaceutical Executive